About Beikang Medical
Beikang Medical is a company based in Suzhou (China) founded in 2010.. Beikang Medical has raised $36.52 million across 2 funding rounds from investors including Broad Vision Funds. The company has 497 employees as of December 31, 2024. Beikang Medical has completed 1 acquisition, including BMX Holdco. Beikang Medical operates in a competitive market with competitors including Natera, SYNLAB, Rejuvenate Bio, Novogene Corporation and Progenity, among others.
- Headquarter Suzhou, China
- Employees 497 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Suzhou Basecare Medical Corp. Ltd. Class H
-
Annual Revenue
$41.76 M (USD)41.12as on Dec 31, 2024
-
Net Profit
$-33.09 M (USD)-21.33as on Dec 31, 2024
-
EBITDA
$-33.66 M (USD)-3.78as on Dec 31, 2024
-
Total Equity Funding
$36.52 M (USD)
in 2 rounds
-
Latest Funding Round
$21.13 M (USD), Series C
May 15, 2020
- Investors
-
Employee Count
497
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Beikang Medical
Beikang Medical is a publicly listed company on the HKEX with ticker symbol 2170 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Beikang Medical
Beikang Medical has successfully raised a total of $36.52M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $21.13 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $21.1M
-
First Round
First Round
(11 Sep 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Series C - Beikang Medical | Valuation | Broad Vision Funds |
|
| Sep, 2017 | Amount | Series B - Beikang Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beikang Medical
Beikang Medical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Broad Vision Funds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Consumer technology, healthcare, and sectors are targeted for venture investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beikang Medical
Beikang Medical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BMX Holdco. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Multiple industries are operated by the diversified conglomerate.
|
2022 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Beikang Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beikang Medical Comparisons
Competitors of Beikang Medical
Beikang Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, SYNLAB, Rejuvenate Bio, Novogene Corporation and Progenity, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| domain | founded_year | HQ Location |
BGI is engaged in genomics and precision medicine solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beikang Medical
Frequently Asked Questions about Beikang Medical
When was Beikang Medical founded?
Beikang Medical was founded in 2010 and raised its 1st funding round 7 years after it was founded.
Where is Beikang Medical located?
Beikang Medical is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Is Beikang Medical a funded company?
Beikang Medical is a funded company, having raised a total of $36.52M across 2 funding rounds to date. The company's 1st funding round was a Series B of $15.38M, raised on Sep 11, 2017.
How many employees does Beikang Medical have?
As of Dec 31, 2024, the latest employee count at Beikang Medical is 497.
What is the annual revenue of Beikang Medical?
Annual revenue of Beikang Medical is $41.76M as on Dec 31, 2024.
What does Beikang Medical do?
Beikang Medical was founded in 2010 in Suzhou, China, within the genetic diagnostics sector. NGS-based solutions for neonatal and prenatal applications are developed and offered. Tests including pre-pregnancy, pre-implantation, non-invasive prenatal, and earlyneonatal genetic screening are provided under the Basecare brand. Operations are supported by Daan Gene Corp. of Sun Yat-Sen University, with the domain basecare.cn utilized.
Who are the top competitors of Beikang Medical?
Beikang Medical's top competitors include Natera, Novogene Corporation and BGI.
Is Beikang Medical publicly traded?
Yes, Beikang Medical is publicly traded on HKEX under the ticker symbol 2170.
How many acquisitions has Beikang Medical made?
Beikang Medical has made 1 acquisition, including BMX Holdco.
Who are Beikang Medical's investors?
Beikang Medical has 1 investor. Key investors include Broad Vision Funds.
What is Beikang Medical's ticker symbol?
The ticker symbol of Beikang Medical is 2170 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.